Scandent
lists at Rs190, surges to Rs223
Software
firm Scandent Solutions listed at Rs190 on the bourses
on Wednesday and shot to Rs223.80 within minutes of commencement
of trading.
The stock closed at Rs206.20, with volumes accounting
for more than 51.9 lakh shares on BSE.
Scandent Solutions Corporation has been formed by the
merger of IT services business of SSI and Scandent Solutions.
Post
the merger one new share of Scandent was issued for each
share of SSI.
Scandent Group promoters own 42 per cent of the total
equity in Scandent Solutions Corp and the balance is with
the public.
Back
to News Review index page
Sensex
drops after a five-day rise
Mumbai: The Bombay Stock Exchange index fell 0.3
per cent on Wednesday mainly on profit-booking after rising
consecutively for five days. The Sensex closed below the
6,900-mark at 6,892.82, shedding 22.27 points.
The
sensex opened on a weak note at 6,895.62, as against Tuesday's
all-time closing high of 6,915.09 and dipped marginally
before touching a new intra-day high of 6,954.86.
Thereafter,
selling pressures brought the sensex to an intra-day low
of 6,843.44. The broader 50-share S&P CNX Nifty of
the National Stock Exchange (NSE) shed 8.15 points, closing
at 2,160.80.
Analysts
said that the correction was due for some time now as
the markets were trading at high levels.
Ranbaxy
Laboratories., India's top drugs maker, rose 3.2 per cent
to Rs1,092 while Cipla Ltd. jumped 8.4 per cent to Rs295.5
.
Reliance
Industries Ltd. fell 0.5 per cent to Rs587.4 . It denied
TV reports of plans to merge with group firm Indian Petrochemicals
Corp. Ltd.
Reliance,
with the second-highest weightage in the Bombay-30 share
index, had risen in the morning after a newspaper report
said a mediator had put together a report that could help
resolve a feud within the founding Ambani family.
Wipro
fell 0.4 per cent to Rs714.3 having been weighed
down briefly due to a bomb hoax at one of its Bangalore
offices.
Scandent
Solutions, the former software unit of SSI bought by Scandent
last year, debuted at Rs204 and hit a Rs228 high before
easing to Rs206.65. It was one of the most heavily traded
stocks on the exchange.
The
total turnover on BSE and NSE was pegged at Rs2,943.90
crore and Rs5,700.62 crore, respectively. Foreign institutional
investors (FIIs) were net buyers at Rs498.30 crore on
Tuesday.
The
BSE Consumer Durables index outperformed the other indices
in falling. It shed 2.57 per cent or 40.56 points, at
1,536.8. BPL was down 4.71 per cent at Rs37.45, Titan
Industries fell 2.82 per cent at Rs220.15 and Videocon
was down 4.37 per cent at Rs64.60.
The
banking sector on an upswing in the last few days also
lost ground due to profit-booking. Vijaya Bank was down
6.12 per cent at Rs 69.85, Andhra Bank was down 3.45 per
cent at Rs114.80 and ICICI Bank was down 2.06 per cent
at Rs390.50. Union Bank touched a new low of Rs130.
Back to News Review
index page
Bank
stocks in high demand by FIIs
Foreign
institutional investors' (FII) have been investing heavily
in India's top 25 banks. FII holdings in banks have increased
over 55 per cent from 79 crore shares in January 2004
to 122 crore shares in January 2005. Their bank holdings
now account for 21 per cent or Rs32,931 crore of the total
market capitalisation of Rs1,57,138 crore in January 2005.
The
largest exposure of foreign portfolio investors was in
ICICI Bank (Rs13,008 crore), HDFC Bank (Rs5,163 crore)
and State Bank of India (Rs4,019 crore), Punjab National
Bank, Canara Bank and Bank of Baroda were the other banks
with over Rs1,000-crore exposure.
As
on January 31, 2005, FIIs held 122,63,85,672 shares in
25 banks, up from 78,93,40,406 shares at the end of January
2004.
The
banks that have seen the highest increase in holdings
by FIIs are Indian Overseas Bank, UCO Bank and IDBI Bank.
Bank
holdings accounted for 25.6 per cent of total FII investment
of Rs1,28,718 crore as on January 31, 2005.
Back
to News Review index page
ABN
Amro to issue IPO for Opportunities Fund
Mumbai:
ABN Amro Bank has come out with an equity fund titled,
Asset Management's Opportunities Fund, which opened for
its initial public offer on Wednesday.
This
open-ended equity fund will invest in scrips across market
caps and sectors, company officials said.
The
initial public offer of the scheme will close on March
30. The scheme has the flexibility to actively shift portfolio
concentration between different market capitalisation
buckets. The scheme also retains the flexibility to hold
more concentrated investments in a few sectors than diversified
equity funds.
Mihir
Vora, head of equities, ABN Amro AMC is the fund manager
for the scheme.
Back to News Review
index page
Chola
MF issues dividend on Mid-cap scheme
New
Delhi:
Chola Mutual Fund has issued a third dividend of 10 per
cent on its Mid-cap scheme, which invests primarily in
shares of companies that have a market capitalisation
of Rs 300-3,000 crore.
Investors,
who registered as unitholders as on March 14, would be
eligible for the dividend, according to a statement by
Chola.
Launched
in August 2004, Chola had declared a maiden 10 per cent
on November 24, 2004 and a second dividend of 10 per cent
on January 24, 2005.
Back to News Review
index page
Cipla
zooms on speculation of stake sale
The
stock of domestic pharma firm Cipla shot up sharply due
to market expectations regarding either an acquisition
abroad or plans by the promoters to off-load equity to
multinational drug firms.
The
stock price of Cipla gained 8.4 per cent at Rs295.50 on
the BSE with volumes of 15.77 lakh shares and on the NSE,
closed at Rs295.45, up 8.44 per cent, with volume of 43.60
lakh shares.
Analyst
tracking the company said Cipla's promoters were planning
to off-load equity to a multinational drug firm.
The names of companies doing the rounds were Israeli company
Teva and French company Lab DB Pharma, were named as the
suitors tipped to pick up equity in Cipla.
Amar
Lulla, Cipla's joint managing director, however, denied
both the reports. No reason was given for the optimism
that was fuelling the stock price.
The
Indian promoters hold about 41 per cent equity in Cipla.
Back
to News Review index page
|